Accessibility Tools

Prescribing Information & Guidance


BLMK Primary Care Prescribing Guidance for SGLT2 inhibitors in Heart Failure with Preserved Ejection Fraction (HFpEF)


Minor Update Jan 2024

Approved by BLMK APC Dec 2023

View Document

Guideline Categories: Cardiovascular

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: dapagliflozin, empagliflozin, heart failure, inhibitor, SGLT2, SGLT2 inhibitors, SGLT2i

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net